PRTK

Paratek Pharmaceuticals, Inc.
PRTK

Overview Fund Activity
Delisted

PRTK was delisted on the 20th of September, 2023.

Back to rankings

99 hedge funds and large institutions have $111M invested in Paratek Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 9 closing their positions.

Holders
99
Holders Change
+14
Holders Change %
+16.47%
% of All Funds
2.03%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
23
Increased
35
Reduced
26
Closed
9
Calls
$1.48M
Puts
$708K
Net Calls
+$768K
Net Calls Change
+$670K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$3.57M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$2.46M
3
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$5.32M
4
BlackRock
4
BlackRock
New York
$14.4M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$9.43M

Top Sellers

1
IAM
1
ICM Asset Management
Washington
$798K
2
Balyasny Asset Management
2
Balyasny Asset Management
Illinois
$0
3
APCM
3
Arbiter Partners Capital Management
New York
$0
4
JGC
4
J. Goldman & Co
New York
$435K
5
BCM
5
Bridgeway Capital Management
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Connor, Clark & Lunn Investment Management (CC&L)
101
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$61K -19,336 Closed
Man Group
102
Man Group
United Kingdom
– -$44K -14,025 Closed
Victory Capital Management
103
Victory Capital Management
Texas
– -$40K -12,782 Closed
BRWA
104
B. Riley Wealth Advisors
Florida
– -$38K -11,800 Closed
MAM
105
Meeder Asset Management
Ohio
– -$5K -1,685 Closed
1 2 3 4
5